A detailed history of Prio Wealth Limited Partnership transactions in Merck & Co., Inc. stock. As of the latest transaction made, Prio Wealth Limited Partnership holds 591,160 shares of MRK stock, worth $69.7 Million. This represents 2.27% of its overall portfolio holdings.

Number of Shares
591,160
Previous 582,990 1.4%
Holding current value
$69.7 Million
Previous $63.6 Million 22.73%
% of portfolio
2.27%
Previous 2.2%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$113.24 - $131.95 $925,170 - $1.08 Million
8,170 Added 1.4%
591,160 $78 Million
Q4 2023

Jan 22, 2024

BUY
$100.18 - $109.02 $633,237 - $689,115
6,321 Added 1.1%
582,990 $63.6 Million
Q3 2023

Oct 31, 2023

SELL
$102.95 - $114.33 $1.15 Million - $1.27 Million
-11,136 Reduced 1.89%
576,669 $59.4 Million
Q2 2023

Aug 08, 2023

SELL
$108.61 - $118.38 $1.55 Million - $1.69 Million
-14,251 Reduced 2.37%
587,805 $67.8 Million
Q1 2023

May 12, 2023

SELL
$102.94 - $114.86 $3.98 Million - $4.44 Million
-38,675 Reduced 6.04%
602,056 $64.1 Million
Q4 2022

Feb 13, 2023

SELL
$87.44 - $112.11 $3.37 Million - $4.31 Million
-38,488 Reduced 5.67%
640,731 $0
Q3 2022

Feb 27, 2023

SELL
$84.53 - $94.96 $455,954 - $512,214
-5,394 Reduced 0.79%
679,801 $58.5 Million
Q2 2022

Feb 27, 2023

BUY
$83.49 - $94.64 $3.71 Million - $4.21 Million
44,464 Added 6.94%
685,195 $62.5 Million
Q1 2022

Feb 21, 2023

BUY
$73.51 - $82.4 $3.72 Million - $4.17 Million
50,611 Added 7.9%
691,342 $56.7 Million
Q4 2021

Feb 17, 2022

BUY
$72.28 - $90.54 $829,485 - $1.04 Million
11,476 Added 1.72%
679,219 $52.1 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $1.49 Million - $1.64 Million
20,855 Added 3.22%
667,743 $50.2 Million
Q2 2021

Aug 16, 2021

SELL
$70.31 - $77.77 $150,814 - $166,816
-2,145 Reduced 0.33%
646,888 $50.3 Million
Q1 2021

May 06, 2021

BUY
$68.86 - $81.11 $1.71 Million - $2.02 Million
24,877 Added 3.99%
649,033 $50 Million
Q4 2020

Feb 04, 2021

BUY
$71.77 - $79.65 $1.33 Million - $1.47 Million
18,502 Added 3.05%
624,156 $51.1 Million
Q3 2020

Nov 16, 2020

BUY
$73.18 - $82.95 $675,451 - $765,628
9,230 Added 1.55%
605,654 $50.2 Million
Q2 2020

Aug 11, 2020

BUY
$70.42 - $80.13 $3.27 Million - $3.72 Million
46,423 Added 8.44%
596,424 $46.1 Million
Q1 2020

May 13, 2020

BUY
$63.36 - $87.82 $229,680 - $318,347
3,625 Added 0.66%
550,001 $42.3 Million
Q4 2019

Feb 10, 2020

BUY
$77.58 - $87.54 $382,469 - $431,572
4,930 Added 0.91%
546,376 $49.7 Million
Q3 2019

Nov 13, 2019

SELL
$76.08 - $82.93 $116,402 - $126,882
-1,530 Reduced 0.28%
541,446 $45.6 Million
Q2 2019

Jul 18, 2019

SELL
$69.84 - $81.59 $1.17 Million - $1.37 Million
-16,811 Reduced 3.0%
542,976 $45.5 Million
Q1 2019

May 03, 2019

SELL
$69.58 - $79.36 $512,595 - $584,645
-7,367 Reduced 1.3%
559,787 $46.6 Million
Q4 2018

Feb 06, 2019

BUY
$65.24 - $75.71 $197,546 - $229,249
3,028 Added 0.54%
567,154 $43.3 Million
Q3 2018

Nov 07, 2018

BUY
$57.69 - $67.84 $1.52 Million - $1.78 Million
26,278 Added 4.89%
564,126 $40 Million
Q2 2018

Aug 06, 2018

SELL
$50.83 - $59.72 $483,647 - $568,235
-9,515 Reduced 1.74%
537,848 $32.6 Million
Q1 2018

Apr 17, 2018

BUY
$50.96 - $59.23 $27.9 Million - $32.4 Million
547,363 New
547,363 $29.8 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $299B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Prio Wealth Limited Partnership Portfolio

Follow Prio Wealth Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prio Wealth Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Prio Wealth Limited Partnership with notifications on news.